Showing 361 - 380 results of 111,095 for search '(( 20 c decrease ) OR ( 5 ((((mean decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.64s Refine Results
  1. 361
  2. 362
  3. 363
  4. 364
  5. 365
  6. 366
  7. 367
  8. 368

    Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Boxplot of number of TRAP positive osteoclasts per millimeter of bone surface in MBA-MB-231 tumor-bearing tibiae, showing significantly decreased osteoclasts upon 1D11 treatment, compared to 13C4. …”
  9. 369
  10. 370
  11. 371
  12. 372

    Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

    Published 2013
    “…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”
  13. 373
  14. 374
  15. 375

    CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex. by Teemu Natunen (398069)

    Published 2013
    “…(B) Aβ42-ELISA demonstrates a significant decrease in the soluble Aβ42 levels in the temporal cortex of patients with CC genotype as compared to the TT genotype (*p<0.05, ANOVA LSD, n = 33/34/16, rs7120118 genotypes TT/CT/CC, respectively). …”
  16. 376

    Jurkat and HeLa survival decreases with increasing electric field amplitude and pulse number. by Bennett L. Ibey (357053)

    Published 2013
    “…Data points represent the average survival. (mean +/−s.e., n = 3–5).</p>…”
  17. 377
  18. 378

    Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

    Published 2023
    “…(<b>D</b>) Quantification was presented as a relative difference between the AP-covered LP area in controls and mutants (1.00 ± 0.07 for control, 0.20 ± 0.03 for cKO; <i>n</i> = 4 mice/group). …”
  19. 379
  20. 380